Quanterix is a Massachusetts company with an ultra-sensitive, versatile Covid-19 antigen test, and they are also the company behind the digital health solution Simoa. Quanterix is a Massachusetts-based medical company that has developed a laboratory Covid-19 antigen test that uses an ultra-sensitive single-molecule assay to analyze a number of sample types, including nasal swabs, saliva, or finger-prick blood samples. Prior to the outbreak of Covid-19, Quanterix released the digital health solution Simoa, which allows researchers to closely examine critical biomarkers of infectious diseases. The company focuses on early detection, better prognoses, and enhanced treatment methods. Quanterix’s technology has applications in…
Author: Theresa
Illumina is a San Diego-based company with a unique Next-Generation Sequencing approach that allows for widespread, fast, and accurate Covid-19 testing across the nation. Illumina is a San Diego-based genomics company that has created a “MegaLab” for scaled-up, next-gen Covid-19 testing using genomic sequencing. To date, the company has received over $12 million in funding from the NIH. Originally founded as a startup, Illumina set out to transform human health and explore DNA at an entirely new scale. Prior to the outbreak of Covid-19, Illumina was exploring concepts like the cause of cancer and genetic variations. The company’s key mission…
Biobot Analytics tracks the spread of Covid-19 by analyzing the wastewater of a given population, and this method is cheaper than individual testing while offering earlier warnings and better trend analysis. Biobot Analytics is a Cambridge-based wastewater analysis company with strong links to MIT. With its patented technology, Biobot takes a unique approach to Covid-19 testing. By analyzing wastewater samples, this company can detect spikes in Covid-19 cases before individuals have displayed any symptoms. This approach is cheaper than individual mass testing, and it also offers earlier warnings and superior trend analysis. Founded by students at MIT, Biobot Analytics was…
Luminostics is a medical diagnostics company that specializes in rapid, accurate self-tests for infectious diseases that can be carried out by consumers at home. The company’s expressed mission is to “increase healthcare accessibility and efficiency by designing, developing, manufacturing, and delivering products that enable affordable, widespread access to actionable health testing with immediate follow-up.” In recent months, Luminostics has become one of the global leaders in innovative Covid-19 testing methods. Their unique approach involves an iOS/Android app that integrated with an inexpensive adapter, using nanochemistry and signal processing artificial intelligence to detect and measure viruses with a high level of…
Fluxergy is a medical diagnostics company based in Irvine, California. The company was founded in 2003, and aims to answer the question: “Why is there not a better laboratory testing system on the market that can conduct a variety of tests at the point-of-use?” Over the years, Fluxergy has been developing a high-speed testing platform and an overall system that relies on state-of-the-art polymer chain reaction (PCR) and microfluids technology. The Fluxergy approach makes testing portable and consolidates all of the various processes into one device. This device is easy to use by clinicians in a laboratory setting, and it…
Logan Collins is a futurist, synthetic biologist, author, and innovator. When he was 16, he invented a new antimicrobial protein, OpaL (Overexpressed protein aggregator Lipophilic). Next he developed a bacterial conjugation delivery system for the gene encoding OpaL. His synthetic biology research has been published as a first-author journal article in ACS Biochemistry. In addition, his synthetic biology research has been recognized at numerous venues including TEDxMileHigh, the Intel International Science and Engineering Fair (ISEF), the International BioGENEius Challenge at the BIO International Convention, and at the American Society for Microbiology General Meeting. At Intel ISEF 2014, his synthetic biology…
Conduit founder Ryan Robinson is using quantum engineering to help find a cure for COVID-19. Ryan Robinson is the founder and CEO of Conduit, a provider of hybrid cloud computing models that bring together large amounts of data fast to solve complex problems. Robinson provides hybrid cloud computing models and solutions to help financial administrators make better investment decisions. Ryan graduated from MIT with a double bachelors degree in humanities and Quantum Computing and Information theory. He continued his graduate work in Quantum engineering at MIT.
“Big Pharma” is less important today than it was five years ago. The top eighteen pharmaceutical companies today comprise less than half the value of the sector whereas in 2003 they accounted for over three quarters of the sectors value.